Genmab A/S
CSE:GMAB

Watchlist Manager
Genmab A/S Logo
Genmab A/S
CSE:GMAB
Watchlist
Price: 1 534.5 DKK -1.35% Market Closed
Market Cap: 101B DKK
Have any thoughts about
Genmab A/S?
Write Note

Genmab A/S
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Genmab A/S
Total Receivables Peer Comparison

Comparables:
ZEAL
ASND
B
BAVA
F
FLUO
BIOPOR

Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Genmab A/S
CSE:GMAB
Total Receivables
kr6.2B
CAGR 3-Years
36%
CAGR 5-Years
48%
CAGR 10-Years
52%
Zealand Pharma A/S
CSE:ZEAL
Total Receivables
kr214.1m
CAGR 3-Years
13%
CAGR 5-Years
86%
CAGR 10-Years
69%
Ascendis Pharma A/S
NASDAQ:ASND
Total Receivables
€80.7m
CAGR 3-Years
90%
CAGR 5-Years
99%
CAGR 10-Years
41%
B
Bavarian Nordic A/S
CSE:BAVA
Total Receivables
kr1.1B
CAGR 3-Years
44%
CAGR 5-Years
59%
CAGR 10-Years
25%
F
Fluoguide AS
STO:FLUO
Total Receivables
kr6.4m
CAGR 3-Years
7%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bioporto A/S
CSE:BIOPOR
Total Receivables
kr13.4m
CAGR 3-Years
-6%
CAGR 5-Years
0%
CAGR 10-Years
3%

See Also

What is Genmab A/S's Total Receivables?
Total Receivables
6.2B DKK

Based on the financial report for Jun 30, 2024, Genmab A/S's Total Receivables amounts to 6.2B DKK.

What is Genmab A/S's Total Receivables growth rate?
Total Receivables CAGR 10Y
52%

Over the last year, the Total Receivables growth was 28%. The average annual Total Receivables growth rates for Genmab A/S have been 36% over the past three years , 48% over the past five years , and 52% over the past ten years .

Back to Top